PMDA drug package insert
硝酸イソソルビド注5mg/10mL「タカタ」
PMDA Prescription drug · 高田製薬株式会社 · package insert Mar 8, 2024
Key facts
| Brand names | 硝酸イソソルビド注5mg/10mL「タカタ」, 硝酸イソソルビド注50mg/100mL「タカタ」, 硝酸イソソルビド注5mg/5mL「タカタ」, 硝酸イソソルビド注50mg/50mL「タカタ」, 硝酸イソソルビド注100mg/100mL「タカタ」 |
|---|---|
| Nonproprietary names | 硝酸イソソルビド |
| Companies | 製造販売元／高田製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 冠血管拡張剤 |
| Therapeutic category codes | 872171 |
| YJ codes | 2171404A1042, 2171404A4033, 2171404A2030, 2171404A5056, 2171404A6052 |
| Approval numbers | 22600AMX00800, 22600AMX00801, 22600AMX00802, 22600AMX00803, 22600AMX00804 |
| Package insert edition | 第1版 |
| Package insert date | Mar 8, 2024 |
| PMDA document key | 400186_2171404A1042_1 |
| PMDA company code | 400186 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: